high dose glutathione push IV Revitalize Cells with NAD+ IV

In addition to exposure to environmental toxicants, several genetic risk factors are shared among IBD and PD patients ( ROH3P , HLA , CCNY , LRRK2 , MAPT , SYMPK , RSPH6A , GUCY1A3 , HLA , BTNL2 , and TRIM10 )

Givosiran, a small interfering mRNA therapy, represents a novel and targeted treatment approach and is the only FDA-approved treatment for the prevention of recurrent disabling attacks

Only 9 genes in the mPFC were affected, with no overlap in the NAc

Hepcidin interacts with FPN1 to enhance internalization and degradation, indirectly controlling iron homeostasis

Implications for distinct functions of the two isoforms